Insulin sensitisation for polycystic ovary syndrome: High-dose monotherapy versus low-dose combination

Clin Endocrinol (Oxf). 2024 Mar;100(3):277. doi: 10.1111/cen.15021. Epub 2024 Jan 16.

Authors

Francis de Zegher¹, Lourdes Ibáñez^{2

3}

Affiliations

¹ Leuven Research and Development, University of Leuven, Leuven, Belgium.
² Endocrinology Department, Institut de Recerca Sant Joan de Déu, University of Barcelona, Esplugues, Barcelona, Spain.
³ Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Madrid, Spain.

PMID: 38226544
DOI: 10.1111/cen.15021

No abstract available

Keywords: PCOS; insulin sensitisation; metformin; pioglitazone; spironolactone.

Publication types

Letter
Comment

MeSH terms

Female
Humans
Hypoglycemic Agents / therapeutic use
Insulin / therapeutic use
Insulin Resistance*
Metformin* / therapeutic use
Polycystic Ovary Syndrome* / drug therapy

Substances

Insulin
Hypoglycemic Agents
Metformin